Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia.

Jean-Charles Fruchart
Jean-Charles Fruchart
Université Lille 2

Cardiovasc Diabetol 2017 10 4;16(1):124. Epub 2017 Oct 4.

R3i Foundation, St. Alban-Anlage 46, Basel, Switzerland.

Despite best evidence-based treatment including statins, residual cardiovascular risk poses a major challenge for clinicians in the twenty first century. Atherogenic dyslipidaemia, in particular elevated triglycerides, a marker for increased triglyceride-rich lipoproteins and their remnants, is an important contributor to lipid-related residual risk, especially in insulin resistant conditions such as type 2 diabetes mellitus. Current therapeutic options include peroxisome proliferator-activated receptor alpha (PPARα) agonists, (fibrates), but these have low potency and limited selectivity for PPARα. Modulating the unique receptor-cofactor binding profile to identify the most potent molecules that induce PPARα-mediated beneficial effects, while at the same time avoiding unwanted side effects, offers a new therapeutic approach and provides the rationale for development of pemafibrate (K-877, Parmodia™), a novel selective PPARα modulator (SPPARMα). In clinical trials, pemafibrate either as monotherapy or as add-on to statin therapy was effective in managing atherogenic dyslipidaemia, with marked reduction of triglycerides, remnant cholesterol and apolipoprotein CIII. Pemafibrate also increased serum fibroblast growth factor 21, implicated in metabolic homeostasis. There were no clinically meaningful adverse effects on hepatic or renal function, including no relevant serum creatinine elevation. A major outcomes study, PROMINENT, will provide definitive evaluation of the role of pemafibrate for management of residual cardiovascular risk in type 2 diabetes patients with atherogenic dyslipidaemia despite statin therapy.

Download full-text PDF

Source Listing

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
October 2017
27 Reads

Publication Analysis

Top Keywords

atherogenic dyslipidaemia
peroxisome proliferator-activated
dyslipidaemia despite
residual cardiovascular
proliferator-activated receptor
type diabetes
novel selective
pemafibrate k-877
cardiovascular risk
statin therapy
receptor alpha
development pemafibrate
offers therapeutic
therapeutic approach
approach rationale
rationale development
k-877 parmodia™
modulator spparmα
monotherapy add-on


(Supplied by CrossRef)
Article in Lancet Diabetes Endocrinol.
The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration et al.
Lancet Diabetes Endocrinol. 2014
Article in Obes Rev
LS Adair et al.
Obes Rev 2014
Article in J Am Coll Cardiol
NJ Stone et al.
J Am Coll Cardiol 2014
Article in Eur Heart J
AL Catapano et al.
Eur Heart J 2016
Article in Lancet
J Fulcher et al.
Lancet 2015
Article in N Engl J Med
CP Cannon et al.
N Engl J Med 2015
Article in N Engl J Med
MS Sabatine et al.
N Engl J Med 2017
Article in Cardiovasc Diabetol.
JC Fruchart et al.
Cardiovasc Diabetol. 2013
Article in Atherosclerosis.
Ž Reiner et al.
Atherosclerosis. 2013
Article in Cardiovasc Diabetol.
P Valensi et al.
Cardiovasc Diabetol. 2016
Article in N Engl J Med
PJ Barter et al.
N Engl J Med 2007

Similar Publications

Effects of N-terminal and C-terminal modification on cytotoxicity and cellular uptake of amphiphilic cell penetrating peptides.

Artif Cells Nanomed Biotechnol 2017 Dec 19:1-13. Epub 2017 Dec 19.

i Drug Applied Research Center and Faculty of Pharmacy , Tabriz University of Medical Sciences , Tabriz , Iran.

Purpose: To assess the effect of "N-Acetylation and C-Amidation" on the cellular uptake, cytotoxicity and performance of amphiphilic cell penetrating peptides (CPP) loaded with methotrexate (MTX).

Methods: Several CPPs were synthesized by solid phase peptide synthesis method. Some of these sequences were modified with pyroglutamic acid at N-terminus and benzylamine or memantine at C-terminus. Read More

View Article
December 2017
47 Reads

Indigenous cardiac patients' and relatives' experiences of hospitalisation: A narrative inquiry.

J Clin Nurs 2017 Dec 11;26(23-24):5052-5064. Epub 2017 Oct 11.

School of Nursing, Midwifery and Paramedicine, Australian Catholic University, Brisbane, Qld, Australia.

Aims And Objectives: To explore Indigenous people's experiences of hospitalisation for acute cardiac care.

Background: Indigenous Australians suffer a higher burden of cardiovascular ill health and hospitalisation rates in comparison with other Australians, but there is little research that explores their perspectives of hospitalisation.

Design: Narrative inquiry. Read More

View Article
December 2017
32 Reads
1.23 Impact Factor

Ionizing radiation induces EphA2 S897 phosphorylation in a MEK/ERK/RSK-dependent manner.

Int J Radiat Biol 2017 09;93(9):929-936

b Department of Pharmacology , University of North Carolina , Chapel Hill , NC , USA.

Purpose: The EphA2 tyrosine kinase is frequently overexpressed in human tumors that are also treated with radiation. However, few studies have examined the effect of radiation on the EphA2 receptor itself. The purpose of this project was to investigate the impact of radiation on EphA2 to better understand mechanisms of radioresistance. Read More

View Article
September 2017
12 Reads
1 PubMed Central Citation(source)
1.84 Impact Factor

Harvesting energy of interaction between bacteria and bacteriophage in a membrane-less fuel cell.

Bioresour Technol 2013 Nov 23;147:654-7. Epub 2013 Aug 23.

Department of Chemical Engineering and DST Unit on Soft Nanofabrication, Indian Institute of Technology Kanpur, 208016, India; Center for Environmental Science and Engineering, Indian Institute of Technology Kanpur, 208016, India.

When a fuel and oxidant flow in laminar contact through a micro-fluidic channel, a sharp interface appears between the two liquids, which eliminate the need of a proton exchange membrane. This principle has been used to generate potential in a membrane-less fuel cell. This study use such a cell to harvest energy of interaction between a bacteria having negative charge on its surface and a bacteriophage with positive and negative charges on its tail and head, respectively. Read More

View Article
November 2013
8 Reads
4.49 Impact Factor

A clinically viable index for quantifying denture plaque.

Quintessence Int 1996 Aug;27(8):569-73

Department of Restorative Dentistry, National University of Singapore, Faculty of Dentistry, Singapore.

A denture plaque index using the dye disclosing method was evaluated in 24 patients with Type II denture stomatitis and 17 control subjects with healthy palatal mucosa. Patients with denture stomatitis had statistically significantly higher plaque scores than did controls, indicating a quantitative increase in denture plaque in patients with denture stomatitis. When this plaque index was tested by two examiners for intraexaminer and interexaminer reproducibility, it yielded a 92% to 96% reproducibility. Read More

View Article
August 1996
9 Reads
2 PubMed Central Citations(source)
0.73 Impact Factor